Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-04

FDA Approved: ALLERGY RELIEF — Supplemental Application (WALMART INC. (see also Equate))

View source ↗

Summary

FDA approved a supplemental application for ALLERGY RELIEF containing fexofenadine HCl, manufactured by Walmart Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLERGY RELIEF (cetirizine hydrochloride)

Snippet

SUPPL AP for ALLERGY RELIEF (FEXOFENADINE HCL)